1 Min Read
NEW YORK, Feb 12 (Reuters) - ZIOPHARM Oncology Inc : * Jumps 14.5 percent to $4.57 in premarket after palifosfamide reached target number of progression-free survival events
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.